ACE inhibitors combined with calcium channel blockers resulted in a significantly higher reduction of urinary albumin excretion than other antihypertensive drug groups (P<0.05).
Observational (n=39)
Do different antihypertensive drug regimens reduce urinary albumin excretion in non-diabetic patients with chronic renal disease and hypertension?
In non-diabetic patients with hypertension and chronic kidney disease, combining ACE inhibitors with calcium channel blockers provides superior reduction in urinary albumin excretion compared to other regimens.
p-value: p=< 0.05
Abstract Arterial hypertension and proteinuria are important factors associated with the progression of both diabetic and nondiabetic chronic kidney disease. The objective of the present study was to determine the influence of different antihypertensive drug groups on urinary albumin excretion (UAE) as related to blood pressure in non-diabetic population. Subjects (n=39) with chronic renal disease accompanied by mild to moderate hypertension and varying degrees of proteinuria were divided into 3 groups based on UAE values and placed on nonpharmacological and/or treatment with an antihypertensive drug regimen (consisting of one or more antihypertensive drugs beta blocker, ACE inhibitor or calcium-channel blocker) to achieve a target blood pressure ≤ 130/85 mmHg. Periodic UAE measurements were performed. A reduction was observed over time in most patients, however, it reached statistical significance only in the microalbuminuric group (P<0.01). Patients were further stratified into 5 groups depending on assigned therapy: 0, nonpharmacological treatment; 1-drug group 1; 12-drug groups 1 and 2; 13-drug groups 1 and 3; 123-all 3 drug groups (1-ACE inhibitors, 2-beta blockers, 3-calcium channel blockers). A statistically significant change in mean UAE values at the start and end of the study period in patients assigned to drug groups 12, 13, and 123 was achieved (P < 0.05). Also, there was a statistically significant difference in the average reduction of proteinuria under varying antihypertensive drug regimens (P < 0.05). In conclusion, in patients with hypertension, changes in UAE depend on initial UAE values and administered antihypertensive treatment. ACE inhibitors combined with calcium channel blockers resulted in a higher UAE reduction than other drug groups.
Jović et al. (Thu,) conducted a observational in Chronic renal disease with mild to moderate hypertension and proteinuria (n=39). Antihypertensive drug regimens (ACE inhibitors, beta blockers, calcium channel blockers) vs. Nonpharmacological treatment or other drug groups was evaluated on Urinary albumin excretion (UAE) (p=< 0.05). ACE inhibitors combined with calcium channel blockers resulted in a significantly higher reduction of urinary albumin excretion than other antihypertensive drug groups (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: